Payment overview · 2025
General Payments
$148.71
4 reported records · 2 companies
Healthcare provider profile · identity verified
David G Morales, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BROWNWOOD, TX · NPI 1265468326
Verified facts
What the public records show
CMS Open Payments records show David G Morales, M.D. received $148.71 in general payments during 2025 across 4 reported records.
Imperative Care, Inc accounted for 55.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 464 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $81.73 | 55.0% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $66.98 | 45.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $148.71 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $81.73 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $66.98 | 3 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $38.00 | 2 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $28.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 464 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
464 | 54 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
11 | 11 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 620 | 145 |
| Levothyroxine Sodium | Levothyroxine Sodium | 619 | 126 |
| Furosemide | Furosemide | 541 | 92 |
| Eliquis | Apixaban | 464 | 54 |
| Gabapentin | Gabapentin | 405 | 71 |
| Losartan Potassium | Losartan Potassium | 397 | 101 |
| Pantoprazole Sodium | Pantoprazole Sodium | 391 | 88 |
| Potassium Chloride | Potassium Chloride | 379 | 51 |
| Amlodipine Besylate | Amlodipine Besylate | 319 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 312 | 59 |
| Metoprolol Succinate | Metoprolol Succinate | 299 | 64 |
| Lisinopril | Lisinopril | 266 | 57 |
| Trazodone Hcl | Trazodone Hcl | 248 | 40 |
| Carvedilol | Carvedilol | 246 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 241 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 219 | 28 |
| Mirtazapine | Mirtazapine | 214 | 38 |
| Metformin Hcl | Metformin Hcl | 213 | 62 |
| Sertraline Hcl | Sertraline Hcl | 192 | 31 |
| Spironolactone | Spironolactone | 191 | 43 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 182 | 43 |
| Clopidogrel | Clopidogrel Bisulfate | 179 | 38 |
| Omeprazole | Omeprazole | 152 | 46 |
| Memantine Hcl | Memantine Hcl | 143 | 25 |
| Jardiance | Empagliflozin | 142 | 29 |
| Amiodarone Hcl | Amiodarone Hcl | 136 | 17 |
| Meloxicam | Meloxicam | 136 | 45 |
| Simvastatin | Simvastatin | 135 | 34 |
| Finasteride | Finasteride | 119 | 17 |
| Levetiracetam | Levetiracetam | 116 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 111 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 109 | 35 |
| Donepezil Hcl | Donepezil Hcl | 107 | 18 |
| Allopurinol | Allopurinol | 103 | 25 |
| Montelukast Sodium | Montelukast Sodium | 101 | 20 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 100 | 30 |
| Hydralazine Hcl | Hydralazine Hcl | 96 | 16 |
| Prednisone | Prednisone | 94 | 69 |
| Xarelto | Rivaroxaban | 93 | 13 |
| Hydrochlorothiazide | Hydrochlorothiazide | 91 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 90 | 25 |
| Alprazolam | Alprazolam | 88 | 19 |
| Divalproex Sodium | Divalproex Sodium | 88 | 12 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 84 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 77 | 16 |
| Alendronate Sodium | Alendronate Sodium | 75 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 74 | 23 |
| Entresto | Sacubitril/Valsartan | 70 | suppressed |
| Olanzapine | Olanzapine | 70 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 69 | 15 |
| Myrbetriq | Mirabegron | 69 | suppressed |
| Azithromycin | Azithromycin | 67 | 53 |
| Farxiga | Dapagliflozin Propanediol | 67 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 63 | 46 |
| Baclofen | Baclofen | 62 | suppressed |
| Glipizide | Glipizide | 60 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 60 | 12 |
| Pregabalin | Pregabalin | 60 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 60 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 58 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 57 | 20 |
| Ozempic | Semaglutide | 56 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 55 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 52 | suppressed |
| Trulicity | Dulaglutide | 52 | suppressed |
| Lorazepam | Lorazepam | 51 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 51 | 12 |
| Torsemide | Torsemide | 51 | suppressed |
| Sucralfate | Sucralfate | 50 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 50 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 49 | 21 |
| Midodrine Hcl | Midodrine Hcl | 49 | suppressed |
| Glimepiride | Glimepiride | 48 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 47 | 11 |
| Famotidine | Famotidine | 46 | suppressed |
| Fenofibrate | Fenofibrate | 46 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 46 | 18 |
| Clonidine Hcl | Clonidine Hcl | 45 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 45 | 17 |
| Bupropion Xl | Bupropion Hcl | 43 | suppressed |
| Cephalexin | Cephalexin | 43 | 19 |
| Clonazepam | Clonazepam | 43 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | 12 |
| Januvia | Sitagliptin Phosphate | 43 | suppressed |
| Ezetimibe | Ezetimibe | 41 | 13 |
| Nebivolol Hcl | Nebivolol Hcl | 41 | 12 |
| Temazepam | Temazepam | 41 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 41 | suppressed |
| Levofloxacin | Levofloxacin | 40 | 36 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 40 | suppressed |
| Aripiprazole | Aripiprazole | 39 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 39 | 14 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 37 | suppressed |
| Methocarbamol | Methocarbamol | 36 | 11 |
| Novolog | Insulin Aspart | 35 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 34 | suppressed |
| Fluconazole | Fluconazole | 34 | 28 |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Fentanyl | Fentanyl | 33 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 33 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 32 | suppressed |
| Carbamazepine | Carbamazepine | 31 | suppressed |
| Lamotrigine | Lamotrigine | 31 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | 11 |
| Clindamycin Hcl | Clindamycin Hcl | 27 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 18 |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Ranolazine Er | Ranolazine | 27 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 20 |
| Lovastatin | Lovastatin | 26 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 26 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 25 | suppressed |
| Creon | Lipase/Protease/Amylase | 25 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 24 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 24 | suppressed |
| Latanoprost | Latanoprost | 24 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 24 | suppressed |
| Estradiol | Estradiol | 23 | suppressed |
| Glipizide Er | Glipizide | 23 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 23 | suppressed |
| Mounjaro | Tirzepatide | 23 | suppressed |
| Phenytoin | Phenytoin | 23 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 22 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Naproxen | Naproxen | 22 | suppressed |
| Nystatin | Nystatin | 22 | 14 |
| Ceftriaxone | Ceftriaxone Sodium | 21 | 13 |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Haloperidol | Haloperidol | 21 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 20 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 19 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Ertapenem | Ertapenem Sodium | 18 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Sotalol | Sotalol Hcl | 17 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 15 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Insulin Lispro | Insulin Lispro | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Gvoke Hypopen 1-Pack | Glucagon | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 14 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 12 |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Nystop | Nystatin | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 11 | suppressed |
| Gemtesa | Vibegron | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Risperidone | Risperidone | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $148.71 · 4 records | Imperative Care, Inc | ELIQUIS, NURTEC ODT, SYMPHONY CATHETER, ZAVZPRET | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error